28 Apr2021

EP PerMed Information Day on May 31, 2021- Registration is open

Written by Mª Cristina Nieto. Posted in News

The initiatives ERA PerMed and ICPerMed invite all interested stakeholders, in particular national and regional authorities (as ministries, funders, etc.) to the virtual event “European Partnership for Personalised Medicine calling for national and regional involvement” to inform about ICPerMed and ERA PerMed’s proposal for EP PerMed, its objectives, activities and expected impacts and the overall framework for engagement in this partnership.

Aim of the information day is to engage with national and regional authorities, funders and stakeholders interested in promoting and implementing personalised medicine approaches in their countries and regions to foster personalised diagnostics, therapy and prevention for the benefit of patients and citizens.

The virtual event will take place on May 31, 2021 (13.00 – 16.30 CEST). 

A draft agenda can be found here.

If you are interested to join the event, please register here!

22 Apr2021

Guide to a European Partnership for Personalised Medicine

Written by Mª Cristina Nieto. Posted in News

ERA PerMed and ICPerMed published a jointly developed guide for the candidate European Partnership for Personalised Medicine – EP PerMed.

The guidance document was developed by the ICPerMed and ERA PerMed “Preparatory Group”, comprising of four representatives of each initiative, and aims to provide information about the European Partnerships developed in the 9th framework programme of the European Union and in particular for the European Partnership for Personalised Medicine (EP PerMed).

It is intended to provide support for representatives of national and regional authorities, ministries, funders and policy makers and the Personalised Medicine stakeholder community. The path towards the EP PerMed is work in process. Thus, this guideline is a dynamic document that will be updated when new information or developments become available.

In addition, topic-specific one-pagers will soon be available for relevant topics.

This document was jointly developed by ERA PerMed and ICPerMed as guide for decision-makers and stakeholders in the preparation of the candidate European Partnership in Personalised Medicine, EP PerMed. The document received valuable input of the European Commission (EC) but does not represent an official document developed and approved by the EC.

With this document, ICPerMed and ERA PerMed aim to promote the EP PerMed. Information on the EP PerMed preparations and recommendations for regional/national organisations in preparation of the European Partnership are provided, to foster participation of interested organisations in the EP PerMed and help organising the baselines for preparations on the regional and national level to mobilise the national budget commitments and receive stakeholder input for the creation of the partnership.

Contact details ICPerMed/ERA PerMed preparatory group:

Download: Guide to a European Partnership for Personalised Medicine
For further information, you can find the EP PerMed draft concept paper here.

15 Apr2021

Regions4PerMed- Personalising Health Industry Workshops

Written by Mª Cristina Nieto. Posted in News

R4PM_TEMA_03-Health-industry_WORKSHOP_FB_800x650_01-COMPLETA_2021-04-07

CSA Regions4PerMed invites to two Workshops on Personalising Health Industry:

1st Workshop, April 28th 2021, 1-4 p.m.

“A Regional R&D Ecosystem for Personalising Health Industry – Spotlight on the Free State of Saxony”

A thriving R&D ecosystem is a facilitator and an important resource for innovation in almost any scientific field. The concept of R&D innovation ecosystem implies that academic R&D-related innovation potential feeds into industry and vice versa. Relations are manifold, with proximity and closer social contacts between actors and supporting structures ´such as tech transfer and cluster organisations serving as catalysers. These ecosystems may enhance industry development by providing essential R&D infrastructures for personalised medicine and health, as much as by generating qualified human resources. A well-functioning regional R&D ecosystem may offer high-tech services on one hand, and on the other guidance by generating role models for entrepreneurship and the translation of scientific breakthroughs into tangible innovative products. To find out more and register please go here.

2nd Workshop, May 19th 2021, 1-4 p.m.

“Regional Translational Ecosystems Supportive of Personalising Health Industry”

Bringing innovation from the R&D phase to the market requires translational and frequently also entrepreneurial efforts. However, to realize these has long been identified as a bottle-neck resulting in a valley of death for many projects. To pass this gap, it has been proposed and discussed, to reduce the risk profile of new ventures and translational activities by providing comprehensive early-stage support schemes and structures. De-risiking is also seen as an important strategy to counteract against the lack of risk capital availability throughout Europe. Though this idea is not entirely novel, as first business incubators for the life sciences were already set up in the late 90s in Europe, the concepts have been developed further and become more refined, and relevant expertise has grown as structures have institutionalised and professionalised. To find out more and register please go here.

18 Feb2021

Draft Concept Paper “European Partnership for Personalised Medicine – EP PerMed”

Written by Mª Cristina Nieto. Posted in News

ICPerMed and ERA PerMed published a jointly developed draft concept paper for the candidate European Partnership for Personalised Medicine – EP PerMed.

With this document, ICPerMed and ERA PerMed underline the need for establishing a European Partnership for Personalised Medicine and propose their vision for EP PerMed, its objectives, activities and expected impacts. It also outlines the composition of the partnership consortium and its interaction with the Personalised Medicine ecosystem, on European and international level.

The EP PerMed draft concept paper was prepared between June-August 2020 by the ICPerMed and ERA PerMed “Preparatory Group”, comprising of four representatives of each initiative. The group received valuable input of the European Commission. The draft concept paper was presented and discussed during a Joint Sustainability Workshop of ERA PerMed and ICPerMed beginning of September. It is a living document and will be further developed and updated after input of other stakeholders. Its current version was provided to the European Commission after receiving the approval by the over 50 organisations of more than 30 countries (24 European countries) involved in both initiatives in October 2020.

This draft concept paper was jointly developed and approved by the ICPerMed and ERA PerMed consortia as input and supporting document for the Member States consultation on the candidate European Partnership in Personalised Medicine, EP PerMed, organised by the EC. The document received valuable EC input but does not represent an official document developed and approved by the EC. The document is not the official partnership proposal.

Over the last years, already a lot has been achieved in the field of personalised medicine by a large number of international, pan-European, national as well as regional activities and initiatives. But to further develop and foster promising personalised medicine approaches, there is a need of an even closer collaboration and effort which could be achieved by a European Partnership for Personalised Medicine in Horizon Europe.

With its next research and innovation framework programme Horizon Europe, the European Union will support European Partnerships with EU countries, the private sector, foundations and other stakeholders.

Contact details ICPerMed/ERA PerMed preparatory group:

ICPerMed: ICPerMed@dlr.de

ERA PerMed: ERAPerMed@agencerecherche.fr

Download: Draft concept paper “European Partnership for Personalised Medicine – EP PerMed”

04 Feb2021

ERIC Forum Cross-Domain Workshop on Research Quality and Reproducibility

Written by Mª Cristina Nieto. Posted in News

As part of the ERIC Forum Implementation Project, EATRIS is organising a cross-domain workshop on the subject of quality and reproducibility in the research process.

The workshop aims to bring together the Research Infrastructures’ community, academics, policy makers and funders to exchange best practices and explore challenges in the design and execution phase of research, and features speakers from all scientific disciplines of the ERIC Forum.

The event will be virtual on 10th (13:30-17:00 CET) and 11th (9:30-12:30 CET) February 2021. 

The programme of the event, the registration link and more information can be found here.